Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Discover which cards have the best benefits to maximize your rewards. Make informed choices for better financial outcomes.
26,924 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
A market dip in the chip sector created a rare buying opportunity. This guide features three thoughtful picks to own ...
Amazon and Shopify posted contrasting Q1 2026 results, underscoring a widening gap between a capital-heavy expansion ...
A major AI cloud deal sparked a notable move in CoreWeave stock on Wednesday. This article explains what happened, wh...
Tether’s move to undergo a Big Four audit has crypto markets buzzing. This deep dive explains why the name of the aud...
A pivotal Investor Day pushed Schwab stock higher on Friday as management raised guidance on revenue growth and net i...
Rivian is rolling out its smaller R2 SUV, and deliveries have begun. As investors watch the headlines, the big questi...
Gabelli’s team signals a long-running capex wave in defense, benefiting both the big primes and smaller suppliers. Al...
Intel Arrow Lake Refresh introduces budget-friendly CPUs with stronger cores, bigger caches, and aggressive pricing. ...
Shopify beat expectations with robust 2025 results, while Amazon posted strong 2026 numbers, underscoring a clear spl...
An obscure AI-focused ETF has outperformed the Nasdaq by concentrating on hard-to-access AI players in Korea and Taiw...